PTHS

PELTHOS THERAPEUTICS INC

PTHS·171126204·US·Common Stock·Healthcare - Biotechnology-Activist

PTHS (PELTHOS THERAPEUTICS INC) is held by 11 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.7M), CANTOR FITZGERALD, L. P. ($1.1M), CITADEL ADVISORS LLC ($425,200). Net institutional sentiment: Mixed.

11
Holders
$5.4M
Total Value
67% (12)
Consensus
8 buying - 4 selling
13F: Insider & Congress: Updated regularly
PTHS

Smart Money Verdict

View all
Loading verdict
Held by 11 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jul 7, 2026 · Activists May 15, 2026 · Congress none

InsiderGPGreenleaf PeterSell $19KJul 2, 2026
InsiderFMFriedberg Ezra MSell $14KJul 2, 2026
InsiderGPGreenleaf PeterSell $2KJul 2, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
97,134(+4.3%)$2.7M0.0%+9.94%
27
Decreased
38,123(-8.0%)$1.1M0.0%-0.73%
0
New
15,046$425,2000.0%-5.24%
37
Decreased
14,650(-4.2%)$414,0080.0%-7.10%
0
Increased
9,873(+0.6%)$279,0110.0%+10.60%
23
New
9,800$276,9480.0%-5.24%
36
New
5,324$150,4570.0%-5.24%
34
Increased
2,217(+190.2%)$62,6520.0%-3.18%
23
Unchanged
40$1,1300.0%+10.71%
0
New
20$5650.0%-5.24%
17
Exited
0(-100.0%)$210.0%+16.83%
0
Exited
0(-100.0%)$40,1290.0%-5.80%
0
New
6$00.0%-5.24%
17
PTHSPTHSPELTHOS THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used